Notably, ectopic expression of IGF2BP3 potently increased NANOG, OCT4, and CD44 levels in NPC tumors, while silencing IGF2BP3 potently impaired stemness marker levels in tumors (Supplementary Fig. 3B). This evidence concerns the gene POU5F1 and nasopharyngeal carcinoma.